Autoimmune disease model animal

Details Autoimmune disease model animal Autoimmune disease model animal

2006-06-13

2006-06-13

Li, Q. Janice (Department: 1633)

Multicellular living organisms and unmodified parts thereof and

Nonhuman animal

The nonhuman animal is a model for human disease

C800S008000, C800S013000, C424S093100, C424S093210, C424S184100

Reexamination Certificate

active

07060868

ABSTRACT:
Pemphigus vulgaris(PV) is an autoimmune disease with a possible fatality of the skin and mucosae which is induced by an antibody against desmoglein 3 (Dsg3). Persistent production of anti-Dsg3 IgG can be induced by adoptively transferring spleen cells of a DSG3−/− mouse immunized with rDsg3 into an RAG2−/− immunodeficient mouse expressing Dsg3 protein. This IgG in the blood binds to the Dsg3 protein in vivo, induces the breakage of intercellular adhesion of keratinocytes and thus brings about the phenotype ofpemphigus vulgarisinvolving the formation of blisters in the oral mucosa and the disappearance of resting hair. These effects are sustained over 6 months. By using this method, active disease model animals relating to various autoimmune diseases can be constructed.

REFERENCES:
Logan and Sharma, Clin Exp Pharmacol Physiol Dec. 1999; 26:1020-25.
Linder, Lab Animal May 2001;30:34-9.
Mullins et al, J Clin Invest Apr. 1996;97:1557-60.
Yamamura, Prog Exp Tumor Res Basel, Karger, 1999;35:13-24.
Janeways Jr., Immunobiology, 5th Edition, c2001.
Braley-Mullen et al, J Immunol 1994;152:307-14.
Schloot et al, J Autoimmun 1996;9:357-63.
Yanagimachi, Mol Cell Endocrinol 2002;187:241-8.
Denning, Nat Biotech 2001;19:559-562.
Humpherys et al, Science 2001;293:95-97.
Pearson, Nature 2002;415:8-9.
Kaufman et al, J Clin Invest 1992;89:283-292.
Clemente et al, J Clin Endocrin & Metabol 1997;82:1353-61.
Xiao et al, J Clin Invest Oct. 2002;110:955-63.
Aratani et al, Infect Immunity Apr. 1999;67:1828-36.
Amagai et al., “Use of Autoantigen-Knockout Mice in Developing an Active Autoimmune Disease Model for Pemphigus,”J. Clin. Invest.,105(5):625-631 (2000).
Fan et al., “BALB/c Mice Produce Blister-Causing Antibodies Upon Immunization with a Recombinant Human Desmoglein 31,”J. Immunol.,163:6228-6235 (1999).
Ono et al.,Igaku no Ayumi,pp. 282-284 (1995) (abstract).
Amagai et al., “Desmoglein 3 (Pemphigus vulgaris Antigen) as a Major Autoimmune Target in Paraneoplastic Pemphigus and Its Role in Pathogenesis,”J. Invest. Dermatol.,110:482 (1998) (abstract).
Koch et al., “Targeted Disruption of the Pemphigus Vulgaris Antigen (Desmoglein 3) Gene in Mice Causes Loss of Keratinocyte Cell Adhesion with a Phenotype Similar to Pemphigus Vulgaris,”J. Cell Biology, 137(5):1091-1102 (1997).
Juhasz et al., “Development of Pemphigus Vulgaris-Like Lesions in Severe Combined Immunodeficiency Disease Mice Reconstituted with Lymphocytes from Patients,”J. Clin. Invest, 92:2401-2407 (1993).
Stanley, “Cell Adhesion Molecules as Targets of Autoantibodies in Pemphigus and Pemphigoid, Bullous Diseases Due to Defective Epidermal Cell Adhesion,”Adv. Immunol., 53:291-325 (1993).
Goodnow, “Balancing Immunity and Tolerance: Deleting and Tuning Lymphocyte Repertoires,”Proc. Natl. Acad. Sci. USA, 93:2264-2271 (1996).
MacDonald, “Mechanisms of Immunological Tolerance,”Science, 246:982 (1989).
Bach et al., “Are There Unique Autoantigens Triggering Autoimmune Diseases?”Immunol. Rev., 164:139-155 (1998).
Hashimoto et al., “Anti-Cell Surface Pemphigus Autoantibody Stimulates Plasminogen Activator Activity of Human Epidermal Cells,”J. Exp. Med., 157:259-272 (1983).
Anhalt et al., “Induction of Pemphigus in Neonatal Mice by Passive Transfer of IgG From Patients with the Disease,”N. Engl. J. Med., 306:1189-1196 (1982).
Schultz et al., “Development of CD4−CD8−αβTCR+NKI.1+T Lymphocytes,”J. Immunol., 157:4379-4389 (1996).
Koch et al., “Desmoglein 3 Anchors Telogen Hair in the Follicle,”J. Cell Sci., 111:2529-2537 (1998).
Schlitz et al., “Production of Epidermal Acantholysis in Normal Human Skin In Vitro by the IgG Fraction From Pemphigus Serum,”J. Invest. Dermatol., 67:254-260 (1976).
Ishii et al., “Charcterization of Autoantibodies in Pemphigus Using Antigen-Specific Enzyme-Linked Immunosorbent Assays With Baculovirus-Expressed Recombinant Desmogleins,”J. Immunol., 159:2010-2017 (1997).
Amagai et al., “Antigen-Specific Immunoadsorption of Pathogenic Autoantibodies in Pemphigus Foliaceus,”J. Invest. Dermatol., 104:895-901 (1995).
Amagai, “Pemphigus: Autoimmunity to Epidermal Cell Adhesion Molecules,”Adv. Dermatol., 11:319-352 (1996).
Amagai et al., “Autoantibodies Against a Novel Epithelial Cadherin in Pemphigus Vulgaris, a Disease of Cell Adhesion,”Cell, 67:869-877 (1991).
Amagai et al., “Antibodies Against Desmoglein 3 (Pemphigus Vulgaris Antigen) Are Present in Sera from Patients With Paraneoplastic Pemphigus and Cause Acantholysis In Vivo in Neonatal Mice,”J. Clin. Invest., 102:775-782 (1998).
Amagai et al., “Usefulness of Enzyme-Linked Immunosorbent Assay Using Recombinant Desmogleins 1 and 3 for Serodiagnosis of Pemphigus,”Br. J. Dermatol., 140:351-357 (1999).
Dry, “The Coat of the Mouse (Mus musculus),” in Bateson, eds.,Journal of Genetics, vol. XVI. (1926), London: Wm. Dawson & Sons Ltd., pp. 287-340 (reprinted 1963).
Amagai et al., “Absorption of Pathogenic Autoantibodies by the Extracellular Domain of Pemphigus Vulgaris Antigen (Dsg3) Produced by Baculovirus,”J. Clin. Invest., 94:59-67 (1994).
Amagai et al., “Autoantibodies Against the Amino-Terminal Cadherin-Like Binding Domain of Pemphigus Vulgaris Antigen are Pathogenic,”J. Clin. Invest., 90:919-926 (1992).

Affiliated with

Also associated with

Rating

Autoimmune disease model animal does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Autoimmune disease model animal, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Autoimmune disease model animal will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3670343